Liz was previously Managing Director at Kaiser Permanente Ventures, where she pioneered the firm's investment in social enterprises, aligning the investment strategy more closely with the non-profit mission of Kaiser Permanente. She led the firm's investments in Big Health, Groups Recover Together, Everytable, and DexCare, and served on the boards of Big Health, Everytable, KitCheck, OssoVR, Groups (obs), DexCare (obs), and Omada (obs), and as a member of the investment committee for Rock Health.
Prior to KPV, Liz built the health impact investing practice for Imprint Capital, acquired by Goldman Sachs. She spent an interim year between Imprint and KPV helping Acumen design Acumen America and supporting the Robert Wood Johnson Foundation's early impact investing interests.
Her operating background is in commercial ops and new product development on different sides of the healthcare industry: at TriZetto (acquired by Cognizant), the Advisory Board Company (acquired by Optum), and Outcome (acquired by Quintiles).
Liz serves as an advisor to Unseen Capital, on the Investment Committee of Acumen West Africa, and on faculty in Sustainable and Impact Finance at UC Berkeley.